Journal article
Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Abstract
SETTING: Six trials from Haiti, Mexico, the U.S.A., Brazil, Spain, Zambia and Hong Kong.
OBJECTIVE: To evaluate the efficacy and safety of rifampicin plus pyrazinamide (RZ) vs. isoniazid (INH) for the prevention of tuberculosis (TB) among persons with or without human immunodeficiency virus (HIV) infection.
Authors
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Journal
The International Journal of Tuberculosis and Lung Disease, Vol. 10, No. 10, pp. 1080–1090
Publication Date
10 2006
ISSN
1027-3719